Success Stories

NEXTGEN Success Story: Lesedi Steve Alset

A long term pathway from academy development into elite youth football, Segunda Federación and two promotion winning senior teams in Spain.

Lesedi Steve Alset football journey
Academy development → Vázquez Cultural → CD Tudelano → Torremolinos / Mijas → Torremolinos → Primera Federación

For young players and families, Lesedi Steve Alset’s journey is useful because it shows what a pathway looks like when development, timing and real football evidence come before promises. The milestones matter, but so do the periods of preparation, adaptation and patience between them.

Every player pathway is different. NEXTGEN Success Stories document real stages in the journey while keeping the player’s own talent, work, decisions and development at the centre of the story.

The pathway

Academy development → Vázquez Cultural → CD Tudelano → Torremolinos / Mijas → Torremolinos → Primera Federación

Lesedi arrived from South Africa at 15 and spent roughly three years developing in the Spanish academy environment before moving into elite youth and senior football.

His route was not straight. He moved through Vázquez Cultural, CD Tudelano, Juventud Torremolinos and CP Mijas-Las Lagunas before returning to Torremolinos and earning promotion to Primera Federación. Lesedi’s talent, discipline, adaptability and persistence drove the progress; NEXTGEN’s role was to help create a safer, clearer route around that work.

Key milestones

  • Starting point: South Africa · age 15
  • Elite youth step: Vázquez Cultural · División de Honor Juvenil at 18
  • Senior national step: CD Tudelano · Segunda Federación in 2022/23
  • Promotion milestones: Mijas-Las Lagunas to Tercera Federación · Torremolinos to Primera Federación

What this journey demonstrates

Player development is rarely linear. Lesedi’s route shows the value of giving a young player time to develop, taking the right step at the right moment and progressing through performance rather than chasing one short term placement.

Back to News & Insights →